Integra LifeSciences Among Companies to Present At Philly Healthcare/Biotech Stocks Forum Oct. 23
PHILADELPHIA--(BW HealthWire)--Oct. 6, 1999--Leading artificial skin maker Integra LifeSciences Holdings (Nasdaq:IART) is among the presenting companies at the first Informed Investors Philadelphia Healthcare/Biotechnology Stocks Forum on Saturday morning Oct. 23.
The Forum runs from 9 a.m.-1 p.m. Cost is $25 prepaid. Register at www.informedinvestors.com or call 800/992-4683. The Forum will be held at the Doubletree Hotel in Center City.
Integra saw sales for the six months ended June 30 rise to $17.4 million from $8.4 million in the year-earlier period. IART develops, manufactures and markets devices, implants and biomaterials for use in neurosurgery, skin repair and burns, medical products and orthopedics. Integra's CEO Stuart Essig will give the presentation.
INTEGRA(tm) Artificial Skin is used to treat one of out of every 10 severely burned patients in the United States and is the top selling skin substitute the world. The Plainsboro, N.J.-based company sells products in more than 50 countries.
Earlier this year, Integra announced a strategic alliance giving Johnson & Johnson Medical (JNJ) exclusive marketing and distribution rights to INTEGRA(tm) Dermal Regeneration Template(tm) -- the leading engineered skin substitute. The alliance also serves as a foundation for expanding indications and developing future products in the field of skin repair and regeneration.
In addition to Integra, chief executives from several other companies will also be there to interact personally with individual investors. Other presenting companies are: Ribozyme Pharmaceuticals (RZYM) of Boulder, Colo.; AVAX Technologies, Inc. (AVXT) of Kansas City, Mo.; Corvas International (CVAS) of San Diego and Lifemark Corp. (LMRK) of Phoenix. Other presenting companies are pending.
Prominent analyst Alex Zisson, Managing Director and Senior Analyst/Pharmaceuticals at Hambrecht & Quist, is a keynote speaker for the Forum. Zisson covers the larger pharmaceuticals companies and has a special emphasis on the smaller, emerging drug companies (Forest, Jones Medical, Liposome, Medicis, Dura, etc.) and drug delivery. He is a previous member of The Wall Street Journal/Zack's All-Star Analyst Survey.
Since 1993, Sacramento, Calif.-based Informed Investors has featured hundreds of quality companies and scores of industry experts at its Forums.
CONTACT:
Informed Investors
Steve Chanecka/Tim Quast, 916/448-8222 or 800/992-4683 |
